We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Reverse payments

September 2011

Competition Law Insight
Patent litigation in the pharmaceutical industry is a fierce business. Typically, a brand name drug manufacturer is seeking to stop a competitor from selling a “generic” version of the incumbent’s drug that the incumbent believes infringes its hard won intellectual property.


Loading data